FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk. Read More
Novo Nordisk debuts Wegovy weight-loss pill in the U.S. … from CBS Health
January 22, 2026
- How Robbie Robertson Paid Tribute to Richard Manuel in Song … from the American Songwriter Jim Beviglia
- Blackpink’s Lisa Joins Nike As Global Ambassador In Long-Term Partnership … from Maxim Maxim Staff
- Naomi Osaka in bizarre confrontation with opponent after Australian Open victory … from the Independent Jamie Braidwood
- Auction marking the United States’ 250th birthday features some of its most iconic documents … from the Independent Joseph Frederick
Headlines
